Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,728 | 78,868 | 60,360 | 61,666 | 67,151 |
| Marketable Securities | N/A | N/A | N/A | 35,000 | 65,580 |
| Receivables | 115,107 | 111,498 | 108,384 | 81,389 | 71,688 |
| Inventories | 110,425 | 115,926 | 98,804 | 95,996 | 69,369 |
| Income taxes - deferred | 25,188 | 21,477 | 23,606 | 16,884 | 13,778 |
| Other current assets | 18,890 | 28,121 | 14,509 | 11,328 | 11,679 |
| TOTAL | $376,338 | $355,890 | $305,663 | $302,263 | $299,245 |
| Non-Current Assets | |||||
| PPE Net | 199,946 | 189,646 | 141,852 | 99,628 | 65,697 |
| Intangibles | 212,612 | 207,095 | 236,414 | 157,669 | 118,746 |
| Other Non-Current Assets | 19,631 | 12,806 | 18,250 | 0 | 6,988 |
| TOTAL | $432,189 | $409,547 | $396,516 | $257,297 | $191,431 |
| Total Assets | $808,527 | $765,437 | $702,179 | $559,560 | $490,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 813 | 765 | 720 | 678 | 551 |
| Accounts payable and accrued liabilities | 19,133 | 28,006 | 32,510 | 24,374 | 19,842 |
| Accrued Expenses | 104,959 | 91,292 | 89,042 | 72,250 | 56,057 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,191 |
| TOTAL | $256,305 | $295,292 | $223,392 | $124,743 | $106,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,281 | 5,094 | 5,727 | 6,447 | N/A |
| Deferred Revenues | 12,610 | 11,285 | 10,678 | 8,976 | 7,965 |
| Other Non-Current Liabilities | 11,256 | 11,137 | 13,830 | 4,521 | 1,268 |
| TOTAL | $37,643 | $31,951 | $40,464 | $24,956 | $15,100 |
| Total Liabilities | $293,948 | $327,243 | $263,856 | $149,699 | $121,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,123 | 118,258 | 121,909 | 124,554 | 127,409 |
| Common Shares | 9,633 | 9,539 | 9,450 | 9,324 | 4,594 |
| Retained earnings | 824,256 | 702,031 | 585,862 | 490,614 | 396,936 |
| Other shareholders' equity | 14,893 | 8,932 | 25,238 | 12,592 | 2,086 |
| TOTAL | $514,579 | $438,194 | $438,323 | $409,861 | $369,010 |
| Total Liabilities And Equity | $808,527 | $765,437 | $702,179 | $559,560 | $490,676 |